These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Suppression of decorin expression and partial induction of anchorage-independent growth by the v-src oncogene in human fibroblasts. Kolettas E; Rosenberger RF Eur J Biochem; 1998 Jun; 254(2):266-74. PubMed ID: 9660179 [TBL] [Abstract][Full Text] [Related]
26. In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. Tralhão JG; Schaefer L; Micegova M; Evaristo C; Schönherr E; Kayal S; Veiga-Fernandes H; Danel C; Iozzo RV; Kresse H; Lemarchand P FASEB J; 2003 Mar; 17(3):464-6. PubMed ID: 12631584 [TBL] [Abstract][Full Text] [Related]
27. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990 [TBL] [Abstract][Full Text] [Related]
28. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways. Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963 [TBL] [Abstract][Full Text] [Related]
29. Decorin transfection in human mesangial cells downregulates genes playing a role in the progression of fibrosis. Costacurta A; Priante G; D'Angelo A; Chieco-Bianchi L; Cantaro S J Clin Lab Anal; 2002; 16(4):178-86. PubMed ID: 12112390 [TBL] [Abstract][Full Text] [Related]
30. Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction. Markmann A; Hausser H; Schönherr E; Kresse H Matrix Biol; 2000 Dec; 19(7):631-6. PubMed ID: 11102752 [TBL] [Abstract][Full Text] [Related]
31. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. Zhu J; Li Y; Shen W; Qiao C; Ambrosio F; Lavasani M; Nozaki M; Branca MF; Huard J J Biol Chem; 2007 Aug; 282(35):25852-63. PubMed ID: 17597062 [TBL] [Abstract][Full Text] [Related]
32. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702 [TBL] [Abstract][Full Text] [Related]
33. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. Huang HS; Nagane M; Klingbeil CK; Lin H; Nishikawa R; Ji XD; Huang CM; Gill GN; Wiley HS; Cavenee WK J Biol Chem; 1997 Jan; 272(5):2927-35. PubMed ID: 9006938 [TBL] [Abstract][Full Text] [Related]
34. Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells. Alper O; De Santis ML; Stromberg K; Hacker NF; Cho-Chung YS; Salomon DS Int J Cancer; 2000 Nov; 88(4):566-74. PubMed ID: 11058872 [TBL] [Abstract][Full Text] [Related]
35. An antimetastatic role for decorin in breast cancer. Goldoni S; Seidler DG; Heath J; Fassan M; Baffa R; Thakur ML; Owens RT; McQuillan DJ; Iozzo RV Am J Pathol; 2008 Sep; 173(3):844-55. PubMed ID: 18688028 [TBL] [Abstract][Full Text] [Related]
36. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Li Y; Li J; Zhu J; Sun B; Branca M; Tang Y; Foster W; Xiao X; Huard J Mol Ther; 2007 Sep; 15(9):1616-22. PubMed ID: 17609657 [TBL] [Abstract][Full Text] [Related]
37. EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor. Solomon B; Hagekyriakou J; Trivett MK; Stacker SA; McArthur GA; Cullinane C Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):713-23. PubMed ID: 12573759 [TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor acts as a negative regulator for bacterium nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via an Src-dependent p38 mitogen-activated protein kinase signaling pathway. Mikami F; Gu H; Jono H; Andalibi A; Kai H; Li JD J Biol Chem; 2005 Oct; 280(43):36185-94. PubMed ID: 16115866 [TBL] [Abstract][Full Text] [Related]
39. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion. Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194 [TBL] [Abstract][Full Text] [Related]
40. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy. Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]